"FDA approved" labeling statement
Executive Summary
The American Pharmaceutical Assn. asked Sen. Hatch (R-Utah) in Aug. 20 letter for his support of an amendment to the FD&C Act that would require a drug mfr. to include the word "FDA" followed by an NDA number in Rx labeling. APhA said the term would indicate a drug had gone through the approval process but would not mislead consumers as would the term "FDA approved." The assn. maintained that "an indication of FDA approval status would constitute a governmental 'commercial' endorsement of a drug product".
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.